BiotechTube

CSL040 + Placebo

Phase 1Completed
0 watching 0 views this week💤 Quiet
32
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Complement-mediated Disorders

Conditions

Complement-mediated Disorders

Trial Timeline

Sep 28, 2023 → Dec 4, 2025

NCT ID
NCT05937581

About CSL040 + Placebo

CSL040 + Placebo is a phase 1 stage product being developed by CSL for Complement-mediated Disorders. The current trial status is completed. This product is registered under clinical trial identifier NCT05937581. Target conditions include Complement-mediated Disorders.

Hype Score Breakdown

Clinical
10
Activity
5
Company
9
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT05937581Phase 1Completed

Other Products from CSL

IgPro10Approved
84
four factor prothrombin complex concentrateApproved
84
Prothrombin complex concentrate (Human) + Fresh frozen plasma (FFP)Approved
84
IgPro10Approved
84
Blood coagulation Factor VIII and vWF, humanApproved
84